SCP Investment’s Core Laboratories CLB Stock Holding History

SCP Investment’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,800	Closed	-$317K	–	19
2019 Q3	$317K	Buy	+6,800	New	+$316K	0.17%	54

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

SCP Investment's CLB Position: Q4 2019 in Review

SCP Investment sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 6,800 shares — an estimated $317K sold.

SCP Investment first reported a position in CLB in Q3 2019 and held it in 1 quarter. The position peaked at $317K in Q3 2019. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

SCP Investment reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
SCP Investment sold 6,800 Core Laboratories shares in Q4 2019, an estimated $317K.
SCP Investment first reported a position in Core Laboratories in Q3 2019 and held it in 1 quarter.
SCP Investment's Core Laboratories position peaked at $317K in Q3 2019.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on SCP Investment's 13F filing for Q4 2019, filed 30 Jan 2020.